VANCOUVER, British Columbia and PERTH, Australia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- HIGHLIGHTS – FOURTH QUARTERThree new high ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Three new high prospectivity farm-in/JV deals in December 2024, strengthening Novo’s high-quality, Australian based exploration portfolio. Significant new ground position of approximately 1,520 ...

Our product reviews offer independent views with hands-on opinion and honest verdicts aimed to give you all the important information you need to make the best buying decisions.

Geophysical and remote sensing interpretation, coupled with review of existing geochemical datasets identified several targets on Novo's tenure, some of which have seen little to no historical ...

Three new high prospectivity farm-in/JV deals in December 2024, strengthening Novo’s high-quality, Australian based exploration portfolio. Onslow District Western Australia 1 Significant new ground ...

Novo Nordisk has launched its type 2 diabetes pill Rybelsus (semaglutide) in the UK, after cost-effectiveness watchdog NICE decided that there was no need to review it.